Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma.
暂无分享,去创建一个
M. Choti | J. Cameron | T. Pawlik | L. Wood | R. Hruban | C. Iacobuzio-Donahue | M. Hidalgo | B. Edil | elliot k fishman | R. Donehower | R. Schulick | A. Blackford | D. Laheru | A. Wild | Katherine Y. Fan | J. Herman